R N Coler
Overview
Explore the profile of R N Coler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gray S, Coler R, Carter D, Siddiqui A
Prog Mol Biol Transl Sci
. 2016 Aug;
142:291-315.
PMID: 27571699
There is an urgent need to develop new vaccines for tuberculosis, HIV/AIDS, and malaria, as well as for chronic and debilitating infections known as neglected tropical diseases (NTDs). The term...
2.
Reed S, Coler R, Mondal D, Kamhawi S, Valenzuela J
Expert Rev Vaccines
. 2015 Nov;
15(1):81-90.
PMID: 26595093
Visceral leishmaniasis (VL) is a disease transmitted by phlebotomine sand flies, fatal if untreated, and with no available human vaccine. In rodents, cellular immunity to Leishmania parasite proteins as well...
3.
Vallur A, Duthie M, Reinhart C, Tutterrow Y, Hamano S, Bhaskar K, et al.
Clin Microbiol Infect
. 2013 Nov;
20(6):O374-83.
PMID: 24237596
Visceral leishmaniasis in South Asia is a serious disease affecting children and adults. Acute visceral leishmaniasis develops in only a fraction of those infected individuals, the majority being asymptomatic with...
4.
Coler R, Carter D, Friede M, Reed S
Parasite Immunol
. 2009 Aug;
31(9):520-8.
PMID: 19691556
There is a renewed enthusiasm about subunit vaccines for malaria coincident with the formation of new alliances and partnerships raising international public awareness, attracting increased resources and the re-focusing of...
5.
Campos-Neto A, Webb J, Greeson K, Coler R, Skeiky Y, Reed S
Infect Immun
. 2002 May;
70(6):2828-36.
PMID: 12010969
We have recently shown that a cocktail containing two leishmanial recombinant antigens (LmSTI1 and TSA) and interleukin-12 (IL-12) as an adjuvant induces solid protection in both a murine and a...
6.
Campos-Neto A, Netto E, Ovendale P, Coler R, Skeiky Y, Badaro R, et al.
Tuberculosis (Edinb)
. 2002 Jan;
81(5-6):353-8.
PMID: 11800586
Although the tuberculin test has aided in the diagnosis of tuberculosis for more than 85 years, its interpretation is difficult particularly because sensitization with non-tuberculous mycobacteria leads to false positive...
7.
Badaro R, Lobo I, Nakatani M, MUINOS A, Netto E, Coler R, et al.
Braz J Infect Dis
. 2001 Nov;
5(4):223-32.
PMID: 11712967
Immunotherapy has been proposed as a method to treat mucosal leishmaniasis for many years, but the approach has been hampered by poor definition and variability of antigens used, and results...
8.
Campos-Neto A, Porrozzi R, Greeson K, Coler R, Webb J, Seiky Y, et al.
Infect Immun
. 2001 May;
69(6):4103-8.
PMID: 11349082
Leishmaniasis affects approximately 2 million people each year throughout the world. This high incidence is due in part to the lack of an efficacious vaccine. We present evidence that the...
9.
Coler R, Campos-Neto A, Ovendale P, DAY F, Fling S, Zhu L, et al.
J Immunol
. 2001 May;
166(10):6227-35.
PMID: 11342645
The development of an effective vaccine against Mycobacterium tuberculosis is a research area of intense interest. Mounting evidence suggests that protective immunity to M. tuberculosis relies on both MHC class...
10.
Coler R, Skeiky Y, Ovendale P, Vedvick T, Gervassi L, Guderian J, et al.
J Infect Dis
. 2000 Jul;
182(1):224-33.
PMID: 10882601
The purified protein derivative (PPD) skin test has been used for the diagnosis of tuberculosis for more than 75 years. However, the test lacks specificity because all mycobacteria share antigens...